2022 Regular Session • Maryland Legislature
HB1111: Prescription Drug Monitoring Program - Prescribers of Opioids - Notification Requirement
Legislative Summary
Requiring a prescriber to notify the Prescription Drug Monitoring Program as to whether the prescriber has received education regarding the risks of opioid use, is aware that an opioid overdose reversal drug is available, and has prescribed or dispensed an opioid overdose reversal drug if the prescriber prescribes or dispenses an opioid in a dosage of 50 morphine milligram equivalents or more; and prohibiting a prescriber from being required to make the notification more than once for each patient.
Bill History
2/11/2022
First Reading Health and Government Operations
House of Delegates
2/14/2022
Hearing 3/03 at 1:30 p.m.
House of Delegates
Status Information
Current Status
Introduced(2/11/2022)
Chamber
House of Delegates
Committee
Health and Government Operations(House of Delegates)
Sine Die